Risk stratification in nonmuscle-invasive bladder cancer (CME)
Publish date: November 1, 2008
L. Andrew Evans, MD , Edith Canby-Hagino, MD
L. Andrew Evans, MD , Edith Canby-Hagino, MD
By risk-stratifying nonmuscle-invasive bladder cancers, urologists can characterize pathologic subtypes and develop individualized treatment and surveillance strategies.(CME)

